{"retracted":false,"update":{"timestamp":1043712000000,"doi":"10.1212/wnl.60.2.355","type":"correction"},"doi":"10.1212/01.wnl.0000031794.42077.a1","journal":"Neurology","publisher":"Ovid Technologies (Wolters Kluwer Health)","title":"To: Assessment of low-flow CSF drainage as a treatment for AD: Results of a randomized pilot study"}
